Your Messages Inbox
Your Article Summary
See Latest ArticlesNew, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability
Watson Pharmaceuticals, 03/17/09
New Phase 3 data, published in the April issue of The Journal of Urology, show that GELNIQUE Gel 10%, the first and only topical gel approved for the treatment of overactive bladder, is effective at improving the symptoms of urge urinary incontinence, urgency and frequency, and is extremely well tolerated in adults.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Lundbeck initiates clinical phase II trials with Lu AE58054 as augmentation treatment in Alzheimer's disease
Lundbeck, 11/29/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis gains rights to two oral targeted investigational therapies focusing on patients with life-threatening blood disorders and cancers
Novartis, 11/29/09
Major European regulatory milestone in cardiovascular protection for Micardis : Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
Boehringer Ingelheim, 11/29/09
Human genome sciences submits biologics license application to fda for zalbin
Human Genome Sciences, 11/29/09
Article Search
Sponsor